Follow the Lee's Pharmaceutical Holdings Ltd. share price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are quoted on HK HK, under the oversight of HKEX. Market capitalisation: €641.8m. The latest transaction was filed on 8 June 2026 (Purchase). Among the most active insiders: Leelalertsuphakun Wanee. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Lee's Pharmaceutical Holdings Ltd. is a Hong Kong-based pharmaceutical company focused on the development and commercialization of drugs. It specializes in treatments for respiratory diseases, infectious diseases, and metabolic disorders.